1
项与 P10s-PADRE/ MONTANIDE ISA 51 VG(University of Arkansas) 相关的临床试验A Combined Phase i/II Efficacy Study of a Carbohydrate Mimotope-based Vaccine With MONTANIDE™ ISA 51 VG STERILE Combined With Neoadjuvant Chemotherapy in Triple Negative Breast Cancer
The purpose of this study is to evaluate a new investigational cancer vaccine, P10s-PADRE in combination with standard neoadjuvant chemotherapy and surgery in patients with clinical stage I, II or III triple negative breast cancer (TNBC). This study will compare the vaccine plus standard neoadjuvant chemotherapy and surgery to standard neoadjuvant chemotherapy and surgery alone.
100 项与 P10s-PADRE/ MONTANIDE ISA 51 VG(University of Arkansas) 相关的临床结果
100 项与 P10s-PADRE/ MONTANIDE ISA 51 VG(University of Arkansas) 相关的转化医学
100 项与 P10s-PADRE/ MONTANIDE ISA 51 VG(University of Arkansas) 相关的专利(医药)
100 项与 P10s-PADRE/ MONTANIDE ISA 51 VG(University of Arkansas) 相关的药物交易